LDR Announces FDA Clearance Of Its ROI-A™ ALIF Device
Main Category: Neurology / NeuroscienceAlso Included In: Medical Devices / Diagnostics
Article Date: 06 Apr 2009 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
LDR, a total spine solution company, announced that it received FDA clearance on Feb. 2 to market its ROI-A™ implant as an anterior lumbar interbody fusion (ALIF) device. Previously cleared in April 2008 as a partial vertebral body replacement, the ROI-A™ system incorporates the innovative VerteBRIDGE™ screwless plating technology.
The ROI-A™ ALIF is a stand-alone implant system with zero profile, self-locking plates designed for initial and long-term stability. The surgical technique is a direct anterior approach, with the curved plates inserted along the sagittal plane thus requiring no additional exposure to the vertebral bodies.
The ROI-A™ ALIF device is made of PEEK-Optima® for biocompatibility and radiolucency along with Tantalum markers for verification of implant positioning. The system is comprised of multiple footprint sizes, lordotic angles and heights for optimized fit per anatomical requirements. An innovative inserter holds the implant, protecting vascular structures and guiding the plates during insertion.
Christophe Lavigne, CEO of LDR, comments, "Since launching the system in the United States in 2008, close to 500 of the ROI-A devices have been implanted with extremely positive feedback from the surgeons. We are very optimistic about the future of this device for ALIF procedures."
LDR works closely with surgeons to develop implantable spine systems and instrumentation that restore optimum stability and mobility to patients and to make spine surgery more reproducible and easier to perform. More information is located at http://www.ldrholding.com.
Source
LDR
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/145203.php>
APA
http://www.medicalnewstoday.com/releases/145203.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



